Prognostic Value of EGFR Mutation and ERCC1 in Patients with Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy

BACKGROUND: In order to improve the outcome of patients with non-small cell lung cancer (NSCLC), a biomarker that can predict the efficacy of chemotherapy is needed. The aim of this study was to assess the role of EGFR mutations and ERCC1 in predicting the efficacy of platinum-based chemotherapy and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Yamashita, Fumie, Azuma, Koichi, Yoshida, Tsukasa, Yamada, Kazuhiko, Kawahara, Akihiko, Hattori, Satoshi, Takeoka, Hiroaki, Zaizen, Yoshiaki, Kawayama, Tomotaka, Kage, Masayoshi, Hoshino, Tomoaki
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2013
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3734014/
https://ncbi.nlm.nih.gov/pubmed/23940741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0071356
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares